Meet the speaker

Annual ISSCR Meeting 2022 | Innovation Showcases

Patient-derived organoids: a revolutionary new model to advance precision medicine 

16th June 2022 | 11:30 am-12:30 pm PDT | 8:30 pm – 9:30 pm CEST

Abstract: HUB Organoids® have been shown to be a very powerful tool to study the biology of cancer, genetic diseases such as cystic fibrosis, and inflammatory conditions such as IBD or COPD. More recently, the predictive power of HUB Organoids was demonstrated in high-profile publications that show a high correlation of in vitro response with clinical outcome and the feasibility of accelerating a candidate compound to clinical trials in 5 years. HUB has pioneered organoid model development and the optimization of in vitro assays that can be applied to investigate disease biology and perform drug screenings. In her presentation Dr. Sylvia Boj, HUB CSO, will discuss the application of HUB Organoids to precision medicine approaches and how this can benefit patients across various diseases.

Want to know more? Request an in-person meeting with us